Daily Management & Long-Term Monitoring
At a Glance
Children with TRMA need consistent high-dose thiamine and monitoring of blood counts, blood sugar, hearing, vision, and heart rhythm. During illness, follow the sick-day plan, check glucose and ketones as instructed, and seek urgent care if medication cannot stay down or warning signs appear.
Managing Thiamine-Responsive Megaloblastic Anemia (TRMA) requires a shift from searching for a diagnosis to maintaining a sustainable daily routine. Because your child’s body has impaired cellular thiamine transport, their health depends on a consistent supply of high-dose thiamine [1][2].
The Importance of Consistent Treatment
A key rule for TRMA is that thiamine treatment should not be stopped without the prescribing team. While an isolated missed dose is not an immediate emergency, prolonged discontinuation can lead to relapse as the body’s cells run low on energy [2][3].
Stopping thiamine for an extended period can trigger:
- Severe Pancytopenia: This is a dangerous drop in all types of blood cells—red cells, white cells, and platelets [2]. In one case, a patient developed severe pancytopenia five weeks after stopping treatment [2].
- Diabetic Ketoacidosis (DKA): Without thiamine, the pancreas may stop producing enough insulin, leading to dangerously high blood sugar and a buildup of acid in the blood (ketosis) [4][5]. This is a medical emergency that often requires hospitalization [6].
- Heart Rhythm Issues: TRMA is linked to electrical changes in the heart. Stopping thiamine has been shown to trigger supraventricular tachycardia (SVT)—an abnormally fast heartbeat—especially during puberty or periods of illness [5].
Long-Term Monitoring Schedule
Because TRMA affects multiple organs, your child will need regular “surveillance” to catch any changes early. While your doctor will set an individualized schedule based on your child’s baseline findings, standard care typically monitors:
| System | What is Monitored | Why it is Checked |
|---|---|---|
| Hematology | Complete Blood Counts (CBC) | To ensure red blood cells remain healthy and there is no sign of returning anemia [7][8]. |
| Endocrinology | Blood glucose and HbA1c | To track the three-month average of blood sugar [9]. You should also be trained on how to check for ketones if your child becomes ill [6]. |
| Audiology | Hearing tests (audiograms) | Even with treatment, hearing loss can progress in some children [10][6]. If hearing loss becomes severe, your team may discuss cochlear implants, which have been used successfully in TRMA patients [11][4]. |
| Ophthalmology | Dilated eye exams | Routine exams check for changes in the retina (retinitis pigmentosa) or the optic nerve (optic atrophy) [12][13]. |
| Cardiology | Electrocardiograms (ECG) | Used to monitor the heart’s rhythm. Some TRMA patients have a variable finding called “absent P-waves” on their ECG, which requires specialized monitoring to manage the risk of arrhythmias [5][14]. |
Sick Day Management
When a child with TRMA gets a fever, a stomach bug, or a common infection, illness can increase metabolic and diabetes-related risk [6]. During these times, the risk of blood sugar spikes or DKA increases [15]. Oral doses should not be changed or doubled. Strict adherence to the prescribed thiamine protocol and checking glucose/ketones is most important when your child is sick. Do not stop prescribed insulin without endocrinology advice.
If your child is vomiting and cannot keep their medication down, you must contact your medical team immediately for an alternative route, or seek emergency assessment [2].
When to seek urgent care: Go to the ER if your child experiences fainting, sustained palpitations, severe lethargy, rapid/deep breathing, unusual bleeding, severe abdominal pain, confusion, or an inability to keep medication down.
By maintaining a consistent routine and keeping up with individualized specialist appointments, you can help ensure that the “doorway” to energy remains open for your child [16].
Common questions in this guide
Is one missed thiamine dose an emergency for a child with TRMA?
What tests does my child need for long-term TRMA monitoring?
What should we do when a child with TRMA becomes sick?
When should a child with TRMA receive emergency care?
Can hearing loss get worse even when my child takes thiamine?
Why does my child need regular ECGs with TRMA?
Get notified when new evidence is published on Thiamine-responsive megaloblastic anemia syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (16)
- 1
[Thiamine-responsive megaloblastic anemia or Rogers syndrome: A literature review].
Lu H, Lu H, Vaucher J, et al.
La Revue de medecine interne 2019; (40(1)):20-27 doi:10.1016/j.revmed.2018.06.005.
PMID: 30031565 - 2
Pancytopenia in an adult patient with thiamine-responsive megaloblastic anaemia.
Moulin V, Grandoni F, Castioni J, Lu H
BMJ case reports 2018; (2018()) doi:10.1136/bcr-2018-225035.
PMID: 29903777 - 3
Relapse of rare diseases during COVID-19 pandemic: bicytopenia in an adult patient with thiamine-responsive megaloblastic anaemia.
Nouira N, Mansouri R, Tlili R, et al.
The Pan African medical journal 2020; (35(Suppl 2)):139 doi:10.11604/pamj.supp.2020.35.139.25368.
PMID: 33193954 - 4
Childhood thiamine-responsive megaloblastic anemia and diabetes: a case series highlighting early diagnosis and management.
Yılmaz UC, Bhriguvanshi A, Özalp Kızılay D, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2026; (39(7)):733-740 doi:10.1515/jpem-2025-0670.
PMID: 41626659 - 5
Arrhythmia in thiamine responsive megaloblastic anemia syndrome.
Argun M, Baykan A, Hatipoğlu N, et al.
The Turkish journal of pediatrics 2018; (60(3)):348-351.
PMID: 30511554 - 6
First 2 cases with thiamine-responsive megaloblastic anemia in the Czech Republic, a rare form of monogenic diabetes mellitus: a novel mutation in the thiamine transporter SLC19A2 gene-intron 1 mutation c.204+2T>G.
Pomahačová R, Zamboryová J, Sýkora J, et al.
Pediatric diabetes 2017; (18(8)):844-847 doi:10.1111/pedi.12479.
PMID: 28004468 - 7
Case Report: Genetic and Clinical Features of Maternal Uniparental Isodisomy-Induced Thiamine-Responsive Megaloblastic Anemia Syndrome.
Kang P, Zhang W, Wen J, et al.
Frontiers in pediatrics 2021; (9()):630329 doi:10.3389/fped.2021.630329.
PMID: 33816400 - 8
Pharmacogenomics in diabetes: outcomes of thiamine therapy in TRMA syndrome.
Habeb AM, Flanagan SE, Zulali MA, et al.
Diabetologia 2018; (61(5)):1027-1036 doi:10.1007/s00125-018-4554-x.
PMID: 29450569 - 9
Thiamine-Responsive Megaloblastic Anemia-Related Diabetes: Long-Term Clinical Outcomes in 23 Pediatric Patients From the DPV and SWEET Registries.
Warncke K, Prinz N, Iotova V, et al.
Canadian journal of diabetes 2021; (45(6)):539-545 doi:10.1016/j.jcjd.2020.11.006.
PMID: 33388275 - 10
Early thiamine therapy in Rogers syndrome: Systematic review of hematologic, auditory and glycemic outcomes.
Upadhyay Z, Sudani S, Jain A
Bioinformation 2026; (22(1)):26-30 doi:10.6026/973206300220026.
PMID: 41960466 - 11
Thiamine responsive megaloblastic Anemia and deafness: A rare case of Roger's syndrome with successful hearing rehabilitation by cochlear implantation.
Marfatia H, Sahai A, Narkhede K, Sharma M
Journal of otology 2024; (19(3)):163-165 doi:10.1016/j.joto.2024.05.001.
PMID: 39735239 - 12
Leber congenital amaurosis as an initial manifestation in a Chinese patient with thiamine-responsive megaloblastic anemia syndrome.
Wu S, Yuan Z, Sun Z, et al.
American journal of medical genetics. Part A 2022; (188(3)):948-952 doi:10.1002/ajmg.a.62582.
PMID: 34821467 - 13
LONG-TERM MULTIMODAL IMAGING OF OCULAR FINDINGS ASSOCIATED WITH THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA.
Tsui E, Tauber J, Barbazetto I, Gelman SK
Retinal cases & brief reports 2020; (14(3)):247-250 doi:10.1097/ICB.0000000000000686.
PMID: 29210962 - 14
An extremely rare case of Rogers syndrome or thiamine responsive megaloblastic anemia.
Kaur G, Ahuja A, Sen A, et al.
Indian journal of pathology & microbiology 2025; (68(1)):158-160 doi:10.4103/ijpm.ijpm_287_23.
PMID: 38391342 - 15
Beta cell function and clinical course in three siblings with thiamine-responsive megaloblastic anemia (TRMA) treated with thiamine supplementation.
Potter K, Wu J, Lauzon J, Ho J
Journal of pediatric endocrinology & metabolism : JPEM 2017; (30(2)):241-246.
PMID: 28076318 - 16
Survey of patient satisfaction with genetic counseling services in Korea.
Choi IH, Kim YK, Yang SY, et al.
Journal of genetic counseling 2025; (34(1)):e1922 doi:10.1002/jgc4.1922.
PMID: 38769825
This page is for informational purposes only and does not constitute medical advice. Your child’s metabolic, hematology, endocrinology, and other specialist teams should provide the individualized plan, including any medication changes.